Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Gastroenterology. 2021 Nov;161(5):1526-1539.e9. doi: 10.1053/j.gastro.2021.07.026. Epub 2021 Jul 21.
BACKGROUND & AIMS: Preclinical ulcerative colitis is poorly defined. We aimed to characterize the preclinical systemic inflammation in ulcerative colitis, using a comprehensive set of proteins.
We obtained plasma samples biobanked from individuals who developed ulcerative colitis later in life (n = 72) and matched healthy controls (n = 140) within a population-based screening cohort. We measured 92 proteins related to inflammation using a proximity extension assay. The biologic relevance of these findings was validated in an inception cohort of patients with ulcerative colitis (n = 101) and healthy controls (n = 50). To examine the influence of genetic and environmental factors on these markers, a cohort of healthy twin siblings of patients with ulcerative colitis (n = 41) and matched healthy controls (n = 37) were explored.
Six proteins (MMP10, CXCL9, CCL11, SLAMF1, CXCL11 and MCP-1) were up-regulated (P < .05) in preclinical ulcerative colitis compared with controls based on both univariate and multivariable models. Ingenuity Pathway Analyses identified several potential key regulators, including interleukin-1β, tumor necrosis factor, interferon-gamma, oncostatin M, nuclear factor-κB, interleukin-6, and interleukin-4. For validation, we built a multivariable model to predict disease in the inception cohort. The model discriminated treatment-naïve patients with ulcerative colitis from controls with leave-one-out cross-validation (area under the curve = 0.92). Consistently, MMP10, CXCL9, CXCL11, and MCP-1, but not CCL11 and SLAMF1, were significantly up-regulated among the healthy twin siblings, even though their relative abundances seemed higher in incident ulcerative colitis.
A set of inflammatory proteins are up-regulated several years before a diagnosis of ulcerative colitis. These proteins were highly predictive of an ulcerative colitis diagnosis, and some seemed to be up-regulated already at exposure to genetic and environmental risk factors.
临床前溃疡性结肠炎的定义尚不明确。本研究旨在通过一整套蛋白质组学方法,对溃疡性结肠炎的临床前系统性炎症进行特征描述。
我们从基于人群的筛查队列中获得了 72 例以后发生溃疡性结肠炎的个体和 140 例匹配健康对照者的血浆样本(生物样本库)。我们使用邻近延伸分析(一种蛋白质组学检测方法)检测了 92 种与炎症相关的蛋白质。在溃疡性结肠炎患者(n=101)和健康对照者(n=50)的发病队列中对这些发现的生物学相关性进行了验证。为了研究遗传和环境因素对这些标志物的影响,我们还对溃疡性结肠炎患者的健康双胞胎兄弟姐妹(n=41)和匹配健康对照者(n=37)的队列进行了研究。
与对照组相比,基于单变量和多变量模型,6 种蛋白质(MMP10、CXCL9、CCL11、SLAMF1、CXCL11 和 MCP-1)在临床前溃疡性结肠炎中呈上调(P<0.05)。通路分析鉴定出了一些潜在的关键调节因子,包括白细胞介素-1β、肿瘤坏死因子、干扰素-γ、肿瘤坏死因子相关凋亡诱导配体、核因子-κB、白细胞介素-6 和白细胞介素-4。为了验证,我们构建了一个多变量模型来预测发病队列中的疾病。该模型通过留一法交叉验证(曲线下面积=0.92)区分了未经治疗的溃疡性结肠炎患者和对照组。一致的是,MMP10、CXCL9、CXCL11 和 MCP-1 在健康双胞胎兄弟姐妹中明显上调,尽管它们的相对丰度在溃疡性结肠炎发病时似乎更高。
一组炎症蛋白在溃疡性结肠炎诊断前几年就呈上调状态。这些蛋白质对溃疡性结肠炎的诊断具有高度预测性,其中一些似乎在接触遗传和环境危险因素时就已经上调。